| Cat. No. |
Size |
Price |
Figures |
RP11730-5 mg
| 5 mg | $ 142.50 | MSDS: 20080919031106 (PDF)
References:
- Blandini F, et al. Peripheral proteasome and caspase activity in Parkinson disease and Alzheimer disease. Neurology. Feb 2006; 66(4): 529-534.
- Sugano M, et al. RNA interference targeting SHP-1 attenuates myocardial infarction in rats. FASEB J. Dec 2005; 19(14): 2054-2056.
- O'Brien MA, et al. Homogeneous, bioluminescent protease assays: caspase-3 as a model. J. Biomol. Screen. Mar 2005; 10(2): 137-148.
|
|---|
| Full Name | | N-Cbz-Asp-Glu-Val-Asp-AMC |
|
Sequence (one-letter code) |
Z-DEVD-AMC |
Sequence (three-letter code) | ASP-GLU-VAL-ASP-AMC |
| Description | Z-DEVD-AMC is a fluorogenic substrate for caspase 3. Z-DEVD-AMC can be used to continuously measure the activity of caspase-3 in cell extracts using a fluorometer or fluorescence microplate reader. |
|---|
| Solubility | Off-white solid soluble in DMSO |
|---|
| Formula | C36H41N5O14 |
| M.W. | 767.6 |
| Purity | > 95% |
| Storage | Store the peptide at -20 °C and protect it from light. |
| N-Terminal | Z |